“The Immuno-Oncology Curve” with Dr. Steven O’Day – Guests are Alexa Morell, Marianne Pearson and Andrew Wortmann

Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn:

“Happy New Year! I’m starting 2024 with a new episode of my podcast, “The Immuno-Oncology Curve.” It’s a deeply real conversation with Alexa Morell, a colorectal cancer survivor, and two patient advocates: Marianne Pearson, Senior Director of Patient Navigation at Colorectal Cancer Alliance, and Andrew Wortmann, Director of Innovative Marketing at Fight Colorectal Cancer.

We talk about how patients perceive the colorectal cancer treatment and clinical trial landscape, the trend of early-onset diagnoses, the evolving role of immunotherapy, and more.

Listen and subscribe at: https://bit.ly/3RMed3D”

Source: Steven O’Day / LinkedIn

Steven O’Day serves as Agenus’ Chief Medical Officer. He is responsible for leading the expansion of the company’s presence in the I-O field. A pioneer in CTLA-4 inhibition, Dr O’Day played key roles in the advancement of cancer therapies Yervoy and Opdivo, and has been the principal investigator in more than 200 clinical trials. Prior to joining Agenus, he was Executive Director of the John Wayne Cancer Institute and Cancer Clinics at Providence St. John’s Health Center, and Director of the Melanoma and Cutaneous Oncology Research Center. Steven was a visiting scholar in philosophy and medical ethics at Oxford, received his MD from Johns Hopkins, and was a Fellow at the Dana Farber/Harvard Cancer Center.